Hereditary prostate cancer (HPC)
Article published in Urologia Polska 2002/55/3.

authors

Piotr Machoy ¹, Jan Lubiński ²: ¹ Oddział Urologii SPZ ZOZ w Policach
Zarządzający oddziałem: dr Piotr Machoy
² Zakład Genetyki i Patomorfologu PAM w Szczecinie
Kierownik zakładu: prof, dr hab. Jan Lubiński

keywords

prostate, cancer, hereditary prostate cancer

summary

Introduction. This publication presents a problem of hereditary prostate cancer (HPC) and its incidence in the North-West region of Poland.

Material and method. Between 1990 and 1996, in outpatient Clinic of Genetics and Oncology of Pomeranian Academy of Medicine in Szczecin, a genealogy of 420 prostate cancer patients was analysed. Using Carter\'s criteria, the group of hereditary, familial and sporadic prostate cancer were separated.

Results. Hereditary prostate cancer establishes 1.6% of all prostate cancers. In the North-West region of Poland this form of carcinoma of the prostate is observed rarely in comparison with the results from Western Europe.

references

1. Adalgeir A, Barkardottir R, Egilsson V: Linkage analysis of chromosom 17q markers and breast-ovation cancer in Icelandic families and possible relationship to prostatic cancer. Am J Hum Genet 1993: 52:711-717.
2. Cannon L, Bishop D, Skolnick H et al: Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982; 1: 47-50.
3. Carter B, Bova G, Beaty T el al:Hereditary prostate cancer:epidemiologic and clinical features. J Urol 1993; 150: 797-802.
4. Carter B, Bcaty T, Steinberg G et al: Mendelian inheritance of familial prostate cancer, proc. Natl Acad Sci 1992; 89: 3367-3371.
5. Gronwald J, Menkiszak J, Toloczko A, el al: Hereditary breast cancer, Pol J Pathol 1998; 49: 2, 59-66.
6. Machoy P, Lubiński J: Epidemiology of hereditary prostate cancer in North-West Poland. J Cancer Res Clin Oncol 1998; 124 (suppl): 46.
7. Morganti G, Gianferrari L, Cresseri A et al: Recherches cli-nico-statistiques et genetiques sur les negolasies de la prostate. Acta Genet Med Gemellol 1956; 6: 304-305.
8. Neuhausen S, Skolnick M, Cannon-Alloright L: Familial prostate cancer studies in Utah. Br J. Urol 1997; 79 (suppl 1) 15-20.
9. Roberts RO, Bergstralh EJ, Katusic SK et al: Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota. J Uro! 1999; 161:529-531.
10. Smith J, Carpten O, Kallionicerri J et al: Major susceptibility locus for prostate cancer on chromosome 1 revealed byage-nomewide search. Science 1996; 274 Nov 22: 1371-1374.
11. Stephan D, Howell G, Bailey-Wilson J et al: Toward a gene at Xq 27,3 responsible for hereditary prostate cancer (HPC-X). Am J Hum Genet 2000, 4, 67: 16 (abstracts).
12. Walker C, Zeigler-Johnson S, Welsburg K et al: Association of HPC 2/ELAC 2 genotypes and prostate cancer. Am J Hum Genel 2000; 4, 67: 16 (abstracts).
13. Wileska A, Dutkiewicz S, Jarema R: Badania profilaktyczne chorób stercza, Terapia 1999; 2 (73): 3.
14. Woolf C.An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960; 13: 739-741.

correspondence